Overview and Scope
Bone marrow transplantation (BMT) is a specialized treatment for people suffering from certain malignancies or other conditions that involves replacing the bone marrow with healthy cells. The treatment is used to treat blood cell disorders such as leukaemia and lymphoma.
Sizing and Forecast
The bone marrow transplantation market size has grown strongly in recent years. It will grow from $11.09 billion in 2023 to $11.75 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing prevalence of hematologic disorders, improved healthcare infrastructure, rising awareness and education, aging population, government initiatives and support.
The bone marrow transplantation market size is expected to see strong growth in the next few years. It will grow to $14.38 billion in 2028 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to advancements in immunotherapy, increasing demand for allogeneic transplants, expanding applications in non-hematologic diseases, personalized medicine and precision therapeutics, global collaboration and partnerships. Major trends in the forecast period include technological advancements, increasing demand for allogeneic transplants, rising applications in non-malignant diseases, emergence of car-t cell therapies, enhanced pre-transplant diagnostics.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/bone-marrow-transplantation-global-market-report
Segmentation & Regional Insights
The bone marrow transplantation market covered in this report is segmented –
1) By Type: Autologous Bone Marrow Transplant, Allogenic Bone Marrow Transplant
2) By Indication: Hodgkin Lymphoma, Acute Leukaemia, Multiple Myelomas, Solid Tumours, Non-Hodgkin Lymphoma, Other Indications
3) By End-Users: Hospitals, Multispecialty Clinics, Ambulatory Surgical Centers
North America was the largest region in the bone marrow transplantation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global bone marrow transplantation market report forecast period. The regions covered in the bone marrow transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10046&type=smp
Major Driver Impacting Market Growth
The rising prevalence of cancer and other diseases is expected to propel the growth of bone marrow transplantation going forward. Cancer is a severe disorder in which the body’s cells reproduce fast and uncontrollably, resulting in abnormal growth. A bone marrow transplant aims to cure various illnesses and cancers by infusing healthy bone marrow cells into a person after their sick bone marrow has been treated to remove the abnormal cells. It helps in curing the rising occurrence of cancer and other illnesses. For instance, in 2022, according to the reports shared by the American Cancer Society Inc., a US-based nonprofit organization, approximately 1.9 million fresh instances of cancer are projected to be diagnosed, leading to an estimated 609,360 cancer-related fatalities in the United States in 2022. Therefore, the rising prevalence of cancer and other diseases will drive the bone marrow transplantation market.
Key Industry Players
Major companies operating in the bone marrow transplantation market report are Merck Millipore Corporation, Sanofi SA, STEMCELL Technologies Inc., HemaCare Corporation, AllCells LLC, Lonza Group Ltd., Conversant Bio Company, Lifeline Cell Technology LLC, Mesoblast Ltd., PromoCell GmbH, ATCC Inc. (American Type Culture Collection), Diadexus Inc., Qiagen N.V., AGendia Inc., ReachBio LLC, Gamida Cell Ltd., Abbott Laboratories Inc., The Emmes Company LLC, Allogene Therapeutics Inc., Amgen Inc., Angiocrine Biosciences Corp., Astellas Pharma Inc., Atara Biotherapeutics Inc., Bluebird Bio Inc., Cellectis S.A., Celyad SA, Erythrocyte Regeneration and Clinical Therapeutics Inc., Gammacell AB, Gilead Sciences Inc., Graphite Bio Inc., Incyte Corporation, Intellia Therapeutics Inc., Legend Biotech Corporation, Magenta Therapeutics Inc., Novartis AG
The bone marrow transplantation market report table of contents includes:
1. Executive Summary
2. Bone Marrow Transplantation Market Characteristics
3. Bone Marrow Transplantation Market Trends And Strategies
4. Bone Marrow Transplantation Market – Macro Economic Scenario
5. Global Bone Marrow Transplantation Market Size and Growth
…..
31. Global Bone Marrow Transplantation Market Competitive Benchmarking
32. Global Bone Marrow Transplantation Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Bone Marrow Transplantation Market
34. Bone Marrow Transplantation Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
https://topprnews.com/reach-stacker-market-forecast/
https://topprnews.com/remote-health-monitoring-market-trends/
https://topprnews.com/sports-medicine-market-growth/
https://goodprnews.com/surgical-dressing-market-forecast/
https://goodprnews.com/textile-finishing-chemicals-market-size/
https://goodprnews.com/train-control-and-management-systems-market-trends/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
